Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
A new endoscopic duodenal mucosal resurfacing treatment could lead to T2D patients becoming insulin-free.
Read More »Insulin-Free Treatment For T2DM Patients
The Effect of Dapagliflozin on Renal Disease Progression
There is a potential role in using dapagliflozin in patients with CKD.
Read More »Heart Failure in T2DM: Ready for Prime Time?
Although not the most prevalent comorbid condition in patients with T2DM, heart failure was the most fatal in a 17-year long nationwide real-life cohort study.
Read More »Targeting Postprandial Glucose as it Relates to A1C and Cardiovascular Disease
The future of measuring and controlling postprandial glucose using TIR (Time in Range).
Read More »Weekly Semaglutide vs. Daily Sitagliptin in T2D Patients
One diabetes drug showed superior results for A1C reduction and weight loss.
Read More »Unique Shake Improves Glycemic Control in T2D
A clinical pilot study reveals a new way to improve glycemic control by replacing daily breakfast and afternoon snacks with a diabetes-specific nutritional shake.
Read More »Hybrid Closed-Loop Insulin Delivery for Children
Young children with type 1 diabetes often experience greater insulin variability, leading to more complications and a subpar quality of life.
Read More »Should Screening for Type 2 Diabetes Be More Aggressive?
Earlier diagnosis and treatment prevent complications.
Read More »Empagliflozin Outcome on Obstructive Sleep Apnea, Cardiovascular, and Renal Events
The unique benefits of using empagliflozin need to be considered when determining treatments for type 2 patients.
Read More »Impact of Physical Activity and Metformin on Postprandial Glucose
Lifestyle modifications as first-line treatment have paramount importance on the quality of life.
Read More »